Marcio Souza is Director of Aeglea BioTherapeutics, Inc.. Currently has a direct ownership of 90,000 shares of AGLE, which is worth approximately $2.49 Million. The most recent transaction as insider was on Aug 25, 2022, when has been sold 90,000 shares (Common Stock) at a price of $0.56 per share, resulting in proceeds of $50,400. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 90K
0% 3M change
0% 12M change
Total Value Held $2.49 Million

Marcio Souza Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 25 2022
BUY
Open market or private purchase
$50,400 $0.56 p/Share
90,000 Added 50.0%
90,000 Common Stock

Also insider at

PRAX
Praxis Precision Medicines, Inc. Healthcare
MS

Marcio Souza

Director
Austin, TX

Track Institutional and Insider Activities on AGLE

Follow Aeglea BioTherapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AGLE shares.

Notify only if

Insider Trading

Get notified when an Aeglea Bio Therapeutics, Inc. insider buys or sells AGLE shares.

Notify only if

News

Receive news related to Aeglea BioTherapeutics, Inc.

Track Activities on AGLE